Introduction Cancer is a leading cause of death globally. Breast cancer accounts for 30% of all cancer cases and 15% of ...
Mary Bird Perkins Cancer Center and Ochsner Cancer Center—are pushing deeper into underserved communities, deploying new technology and rethinking how care is delivered. The challenges of access, ...
Clinical Trials Arena on MSN
Verastem Oncology’s combo shows two-year durability in ovarian cancer
Verastem’s combination of Avmapki and Fakzynja gained accelerated approval in May 2025 for LGSOC.
A retrospective review suggests that increasing radiation dose from 4 Gy to 8 Gy for indolent B-cell lymphomas is associated with better local control.
Health Minister Mike Nesbitt has highlighted positive progress in breast cancer assessment following the publication of the latest cancer waiting time figures for the quarter ending December 2025. The ...
What was once 25 treatments over five weeks can now often be delivered in 16 treatments, or even as few as five fractions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results